Christopher L. Franklin

Statistics

Publications

Citations

162

H-Index

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The University of Texas at Austin

Christopher L. Franklin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug design, and medicinal chemistry.

Publications per year

2000–2016

Publications

A Novel Class of Zinc-Binding Inhibitors for the Phosphatidylcholine-Preferring Phospholipase C from Bacillus cereus

Stephen F. Martin, Bruce Follows, Paul J. Hergenrother et al. · The Journal of Organic Chemistry · 2000 · 50 citations

Life Sciences, Biochemistry, Pharmacology +13

Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist

Shuwen He, Zhixiong Ye, Peter H. Dobbelaar et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 23 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity

Shuwen He, Zhixiong Ye, Peter H. Dobbelaar et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design, Synthesis, and Evaluation of Water-Soluble Phospholipid Analogues as Inhibitors of Phospholipase C fromBacillus cereus

Christopher L. Franklin, Hui Li, Stephen F. Martin · The Journal of Organic Chemistry · 2003 · 20 citations

Life Sciences, Biochemistry, Pharmacology +15

A Nitrogen-Assisted One-Pot Heteroaryl Ketone Synthesis from Carboxylic Acids and Heteroaryl Halides

Krystyna M. Demkiw, Hirofumi Araki, Eric L. Elliott et al. · The Journal of Organic Chemistry · 2016 · 20 citations

Natural Sciences, Chemistry, Catalysis +16

1–5 of 7